2,964
Views
186
CrossRef citations to date
0
Altmetric
Theme: Alzheimer's disease - Review

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

, , , , , & show all
Pages 677-708 | Published online: 09 Jan 2014

References

  • Qiu C, De Ronchi D, Fratiglioni L. The epidemiology of the dementias: an update. Curr. Opin. Psychiatry20(4), 380–385 (2007).
  • Alzheimer ’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement.6(2), 158–194 (2010).
  • Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement.3(3), 186–191 (2007).
  • Cummings JL. Alzheimer’s disease. N. Engl. J. Med.351(1), 56–67 (2004).
  • Alladi S, Xuereb J, Bak T et al. Focal cortical presentations of Alzheimer’s disease. Brain130(Pt 10), 2636–2645 (2007).
  • Walter J, Kaether C, Steiner H, Haass C. The cell biology of Alzheimer’s disease: uncovering the secrets of secretases. Curr. Opin. Neurobiol.11(5), 585–590 (2001).
  • Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol. Sci.12(10), 383–388 (1991).
  • Lesne S, Koh MT, Kotilinek L et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature440(7082), 352–357 (2006).
  • Shankar GM, Li S, Mehta TH et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med.14(8) 837–842 (2008).
  • Panza F, D’Introno A, Colacicco AM et al. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am. J. Geriatr. Psychiatry13(8), 633–644 (2005).
  • Winblad B, Palmer K, Kivipelto M et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med.256(3), 240–246 (2004).
  • Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol.6(8), 734–746 (2007).
  • Dubois B, Feldman HH, Jacova C et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol.9(11), 1118–1127 (2010).
  • Sachdev P. Vascular cognitive disorder. Int. J. Geriatr. Psychiatry14(5), 402–403 (1999).
  • Roman GC, Sachdev P, Royall DR et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J. Neurol. Sci.226(1–2), 81–87 (2004).
  • Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA292(23), 2901–2908 (2004).
  • Lim A, Tsuang D, Kukull W et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J. Am. Geriatr. Soc.47(5), 564–569 (1999).
  • Sonnen JA, Postupna N, Larson EB et al. Pathologic correlates of dementia in individuals with Lewy body disease. Brain Pathol.20(3), 654–659 (2010).
  • Frisardi V, Solfrizzi V, Imbimbo BP et al. Towards disease-modifying treatment of Alzheimer’s disease: drugs targeting β-amyloid. Curr. Alzheimer Res.7(1), 40–55 (2010).
  • Panza F, Solfrizzi V, Colacicco AM et al. Mediterranean diet and cognitive decline. Public Health Nutr.7(7), 959–963 (2004).
  • Solfrizzi V, Capurso C, D’Introno A et al. Lifestyle-related factors in predementia and dementia syndromes. Expert Rev. Neurother.8(1), 133–158 (2008).
  • Peters R. The prevention of dementia. Int. J. Geriatr. Psychiatry24(5), 452–458 (2009).
  • de la Torre JC. Alzheimer’s disease is incurable but preventable. J. Alzheimers Dis.20(3), 861–870 (2010).
  • Frisardi V, Solfrizzi V, Capurso C et al. Aluminum in the diet and Alzheimer’s disease: from current epidemiology to possible disease-modifying treatment. J. Alzheimers Dis.20(1), 17–30 (2010).
  • Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol.4(8), 487–499 (2005).
  • Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry.16(5), 343–354 (2008).
  • Luchsinger JA, Gustafson DR. Adiposity, Type 2 diabetes, and Alzheimer’s disease. J. Alzheimers Dis.16(4), 693–704 (2009).
  • Frisardi V, Solfrizzi V, Seripa D et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer’s disease. Ageing Res. Rev.9(4), 399–417 (2010).
  • Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr. Rev.68(Suppl. 2) S74–S87 (2010).
  • Panza F, Frisardi V, Capurso C et al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am. J. Geriatr. Psychiatry18(2), 98–116 (2010).
  • Kramer AF, Hahn S, Cohen NJ et al. Ageing, fitness and neurocognitive function. Nature400(6743), 418–419 (1999).
  • Ngandu T, von Strauss E, Helkala EL et al. Education and dementia what lies beneath the association? Neurology69(14), 1442–1450 (2007).
  • Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J. Neural Transm.110(1), 95–110 (2003).
  • Grant WB. Dietary links to Alzheimer’s disease: 1999 update. J. Alzheimers Dis.1(4–5), 197–201 (1999).
  • Luchsinger JA, Mayeux R. Dietary factors and Alzheimer’s disease. Lancet Neurol.3(10), 579–587 (2004).
  • Luchsinger JA, Noble JM, Scarmeas N. Diet and Alzheimer’s disease. Curr. Neurol. Neurosci. Rep.7(5), 366–372 (2007).
  • Coley N, Andrieu S, Gardette V et al. Dementia prevention: methodological explanations for inconsistent results. Epidemiol. Rev.30, 35–66 (2008).
  • Frisardi V, Panza F, Seripa D et al. Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J. Alzheimers Dis.22(3), 715–740 (2010).
  • Solfrizzi V, D’Introno A, Colacicco AM et al. Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp. Gerontol.40(4), 257–270 (2005).
  • Assisi A, Banzi R, Buonocore C et al. Fish oil and mental health. the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int. Clin. Psychpharmacol.21(6), 319–336 (2006).
  • Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer‘s disease. Prog. Lipid Res.48(5), 239–256 (2009).
  • Solfrizzi V, Frisardi V, Capurso C et al. Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms. Ageing Res. Rev.9(2), 184–199 (2010).
  • Dai Q, Borenstein A, Wu Y, Jackson JC, Larson EB. Fruit and vegetable juices and Alzheimer’s disease. the Kame project. Am. J. Med.119(9), 751–759 (2006).
  • Parrott MD, Greenwood CE. Dietary influences on cognitive function with aging. From high-fat diets to healthful eating. Ann. NY Acad. Sci.1114, 389–397 (2007).
  • Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly. a systematic review. Age Ageing37(5), 505–512 (2008).
  • Panza F, Capurso C, D’Introno A et al. Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. J. Alzheimers Dis.17(1), 7–31 (2009).
  • Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Harvard University Press, MA, USA (1980).
  • Serra-Majem L, Roman B, Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr. Rev.64(2 Pt 2), S27–S47 (2006).
  • De Lorgeril M, Salen P, Martin J, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study. Circulation99(6), 799–785 (1999).
  • Willett WC, Sacks F, Trichopoulou A et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am. J. Clin. Nutr.61(6 Suppl.), S1402–S1406 (1995).
  • Sofi F. The Mediterranean diet revisited: evidence of its effectiveness grows. Curr. Opin. Cardiol.24(5), 442–446 (2009).
  • Gomez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat. Rev. Neurosci.9(7), 568–578 (2008).
  • Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer’s disease? J. Alzheimers Dis.20(3), 795–801 (2010).
  • Solfrizzi V, Frisardi V, Seripa D et al. Mediterranean diet in predementia and dementia syndromes. Curr. Alzheimer Res. (2011) (In press).
  • Ortega RM, Requejo AM, Andres P et al. Dietary intake and cognitive function in a group of elderly people. Am. J. Clin. Nutr.66(4), 803–809 (1997).
  • Solfrizzi V, Panza F, Torres F et al. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology52(8), 1563–1569 (1999).
  • Kalmijn S, Feskens EJ, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive functions in very old men. Am. J. Epidemiol.145(1), 33–41 (1997).
  • Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology62(9), 1573–1579 (2004).
  • Kalmijn S, van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology62(2), 275–280 (2004).
  • Solfrizzi V, Colacicco AM, D’Introno A et al. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol. Aging27(11), 1694–1704 (2006).
  • Solfrizzi V, Colacicco AM, D’Introno A et al. Dietary polyunsaturated fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging. Exp. Gerontol.41(6), 619–627 (2006).
  • Psaltopoulou T, Kyrozis A, Stathopoulos P, Trichopoulos D, Vassilopoulos D, Trichopoulou A. Diet, physical activity and cognitive impairment among elders: the EPIC-Greece cohort (European Prospective Investigation into Cancer and Nutrition). Public Health Nutr.11(10), 1054–1062 (2008).
  • Eskelinen MH, Ngandu T, Helkala EL et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int. J. Geriatr. Psychiatry23(7), 741–747 (2008).
  • Vercambre MN, Boutron-Ruault MC, Ritchie K, Clavel-Chapelon F, Berr C. Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women. Br. J. Nutr.102(3), 419–427 (2009).
  • Berr C, Portet F, Carriere I et al. Olive oil and cognition: results from the Three-City study. Dement. Geriatr. Cogn. Disord.28(4), 357–364 (2009).
  • Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann. Neurol.42(5), 776–782 (1997).
  • Engelhart MJ, Geerlings MI, Ruitenberg A et al. Diet and risk of dementia: does fat matter? The Rotterdam Study. Neurology59(12), 1915–1921 (2002).
  • Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch. Neurol.59(8), 1256–1263 (2002).
  • Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ325(7370), 932–933 (2002).
  • Morris MC, Evans DA, Bienias JL et al. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol.60(2), 194–200 (2003).
  • Morris MC, Evans DA, Bienias JL et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol.60(7), 940–946 (2003).
  • Laitinen MH, Ngandu T, Rovio S et al. Fat intake at midlife and risk of dementia and Alzheimer’s disease: a population-based study. Dement. Geriatr. Cogn. Disord.22(1), 99–107 (2006).
  • Barberger-Gateau P, Raffaitin C, Letenneur L et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology69(20), 1921–1930 (2007).
  • Dangour AD, Allen E, Elbourne D, Fletcher A, Richards M, Uauy R. Fish Consumption and cognitive function among older people in the UK: baseline data from the Opal Study. J. Nutr. Health Aging13(3), 198–202 (2009).
  • Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch. Neurol.62(12), 1849–1853 (2005).
  • Nurk E, Drevon CA, Refsum H et al. Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. Am. J. Clin. Nutr.86(5), 1470–1478 (2007) .
  • van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am. J. Clin. Nutr.85(4), 1142–1147 (2007).
  • Huang TL, Zandi PP, Tucker KL et al. Benefits of fatty fish on dementia risk are stronger for those without APOE ε4. Neurology65(9), 1409–1414 (2005) .
  • Panza F, Frisardi V, Capurso C et al. Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer’s disease: a review. ScientificWorldJournal9, 373–389 (2009).
  • Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T et al. ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: Omegad Study: a randomized double-blind trial. Arch. Neurol.63(10), 1402–1408 (2006).
  • Kotani S, Sakaguchi E, Warashina S et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res.56(2), 159–164 (2006).
  • Chiu CC, Su KP, Cheng TC et al. The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog. Neuropsychopharmacol. Biol. Psychiatry32(6), 1538–1544 (2008).
  • Freund-Levi Y, Basun H, Cederholm T et al. Omega-3 supplementation in mild to moderate Alzheimer’s disease: effects on neuropsychiatric symptoms. Int. J. Geriatr. Psychiatry23(2), 161–169 (2008).
  • van de Rest O, Geleijnse JM, Kok FJ et al. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr.88(3), 706–713 (2008).
  • van de Rest O, Geleijnse JM, Kok FJ et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology71(6), 430–438 (2008).
  • Greenwood CE, Winocur G. Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty acid intake. Behav. Neurosci.110(3), 451–459 (1996).
  • Moriguchi T, Greiner RS, Salem N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J. Neurochem.75(6), 2563–2573 (2000).
  • Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid {β}-infused rats. J. Nutr.135(3), 549–555 (2005).
  • Hashimoto M, Hossain S, Shimada T et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer’s disease model rats. J. Neurochem.81(5), 1084–1091 (2002).
  • Calon F, Lim GP, Yang F et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model. Neuron43(5), 633–645 (2004).
  • Florent S, Malaplate-Armand C, Youssef I et al. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid oligomers. J. Neurochem.96(2), 385–395 (2006).
  • Cole GM, Lim GP, Yang F et al. Prevention of Alzheimer’s disease: omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol. Aging26(Suppl. 1), 133–136 (2005).
  • Green KN, Martinez-Coria H, Khashwji H et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci.27(16), 4385–4395 (2007).
  • Park IH, Hwang EM, Hong HS et al. Lovastatin enhances Aβ production and senile plaque deposition in female Tg2576 mice. Neurobiol. Aging24(5), 637–643 (2003).
  • Lim GP, Calon F, Morihara T et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci.25(12), 3032–3040 (2005).
  • Oksman M, Iivonen H, Hogyes E et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on β-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis.23(3), 563–572 (2006).
  • Molteni R, Barnard RJ, Ying Z, Roberts CK, Gómez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience112(4), 803–814 (2002).
  • Ambring A, Friberg P, Axelsen M et al. Effects of a Mediterranean-inspired diet on blood lipids; vascular function and oxidative stress in healthy subjects. Clin. Sci.106(5), 519–525 (2004).
  • Scientific Advisory Committee on Nutrition and the Committee on Toxicity. Advice on Fish Consumption: Benefits and Risks. The Stationery Office, London, UK (2004).
  • Annweiler C, Allali G, Allain P et al. Vitamin D and cognitive performance in adults: va systematic review. Eur. J. Neurol.16(10), 1083–1089 (2009).
  • Annweiler C, Schott AM, Allali G et al. Association of vitamin D deficiency with cognitive impairment in older women. Cross-sectional study. Neurology74(1), 27–32 (2010).
  • Friedland RP. Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations? Arch. Neurol.60(7), 923–924 (2003).
  • Crichton GE, Bryan J, Murphy KJ, Buckley J. Review of dairy consumption and cognitive performance in adults: findings and methodological issues. Dement. Geriatr. Cogn. Disord.30(4), 352–361 (2010).
  • Lee L, Kang SA, Lee HO et al. Relationships between dietary intake and cognitive function level in Korean elderly people. Public Health115(2), 133–138 (2001).
  • Rahman A, Sawyer Baker P, Allman RM, Zamrini E. Dietary factors and cognitive impairment in community-dwelling elderly. J. Nutr. Health Aging11(1), 49–54 (2007).
  • Avila-Funes JA, Garant MP, Aguilar-Navarro S. Relationship between determining factors depressive symptoms and for dietary habits in older adults in Mexico. Rev. Panam. Salud Publica19(5), 321–330 (2006).
  • Almeida OP, Norman P, Hankey G, Jamrozik K, Flicker L. Successful mental health aging: results from a longitudinal study of older Australian men. Am. J. Geriatr. Psychiatry14(1), 27–35 (2006).
  • Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G. Association between dementia and midlife risk factors: the radiation effects research foundation adult health study. J. Am. Geriatr. Soc.51(3), 410–414 (2003).
  • Zemel MB. Role of calcium and dairy products in energy partitioning and weight management. Am. J. Clin. Nutr.79(5), S907–S912 (2004).
  • Zemel MB, Teegarden D, Van Loan MD et al. Dairy-rich diets augment fat loss on an energy-restricted diet: a multicenter trial. Nutrients1(1), 83–100 (2009).
  • Teegarden D. The influence of dairy product consumption on body composition. J. Nutr.135(12), 2749–2752 (2005).
  • Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr. Res. Rev.22(1), 82–92 (2009).
  • Alonso A, Nettleton JA, Ix JH et al. Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis. Hypertension55(3), 776–784 (2010).
  • Weglicki WB, Mak IT, Kramer JH et al. Role of free radicals and substance P in magnesium deficiency. Cardiovasc. Res.31(5), 677–682 (1996).
  • Singh RB, Rastogi SS, Sharma VK, Saharia RB, Kulshretha SK. Can dietary magnesium modulate lipoprotein metabolism? Magnes. Trace Elem.9(5), 255–264 (1990).
  • Ma B, Lawson AB, Liese AD, Bell RA, Mayer-Davis EJ. Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose–dependent association. Am. J. Epidemiol.164(5), 449–458 (2006).
  • Festa A, D’Agostino R, Williams K et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int. J. Obes. Relat. Metab. Disord.25(10), 1407–1415 (2001).
  • Yaffe K, Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African–American and white elders. Neurology61(1), 76–80 (2003).
  • Solfrizzi V, Frisardi V, Capurso C et al. Moderate alcohol consumption, apolipoprotein E, and neuroprotection. Arch. Neurol.66(4), 541–542 (2009).
  • Goodwin JS, Sanchez CJ, Thomas P, Hunt C, Garry PJ, Goodwin JM. Alcohol intake in a healthy elderly population. Am. J. Public Health77(2), 173–177 (1987).
  • Christian JC, Reed T, Carmelli D, Page WF, Norton JA Jr, Breitner JC. Self-reported alcohol intake and cognition in aging twins. J. Stud. Alcohol56(4), 414–416 (1995).
  • Hendrie HC, Gao S, Hall KS, Hui SL, Unverzagt FW. The relationship between alcohol consumption, cognitive performance, and daily functioning in an urban sample of older Black Americans. J. Am. Geriatr. Soc.44(10), 1158–1165 (1996).
  • Launer LJ, Feskens EJ, Kalmijn S, Kromhout D. Smoking; drinking; and thinking. The Zutphen Elderly Study. Am. J. Epidemiol.143(3), 219–227 (1996).
  • Elias PK, Elias MF, D’Agostino RB, Silbershatz H, Wolf PA. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am. J. Epidemiol.150(6), 580–589 (1999).
  • Carmelli D, Swan GE, Reed T, Schellenberg GD, Christian JC. The effect of apolipoprotein E ε4 in the relationships of smoking and drinking to cognitive function. Neuroepidemiology18(3), 125–133 (1999).
  • Bond GE, Burr R, McCurry SM, Graves AB, Larson EB. Alcohol, aging, and cognitive performance in a cohort of Japanese Americans aged 65 and older: the Kame Project. Int. Psychogeriatr.13(2), 207–223 (2001).
  • Bond GE, Burr R., Rice MM et al. Alcohol, aging, and cognitive performance: a cross-cultural comparison. J. Aging Health15(2), 371–390 (2003).
  • Dufouil C, Ducimetière P, Alperovitch A. Sex differences in the association between alcohol consumption and cognitive performance. EVA Study Group. Epidemiology of Vascular Aging. Am. J. Epidemiol.146(5), 405–412 (1997).
  • Schinka JA, Vanderploeg RD, Rogish M, Graves AB, Mortimer JA, Ordoric PI. Effects of the use of alcohol and cigarettes on cognition in elderly adults. J. Int. Neuropsychol. Soc.8(6), 811–818 (2002).
  • Verhaegen P, Borchelt M, Smith J. Relation between cardiovascular and metabolic disease and cognition in very old age: cross-sectional and longitudinal findings from the Berlin aging study. Health Psychol.22(6), 559–569 (2003).
  • Lindeman RD, Wayne SJ, Baumgartner RN, Garry PJ. Cognitive function in drinkers compared to abstainers in the New Mexico Elder Health Survey. J. Gerontol. A Biol. Sci. Med. Sci.60(8), 1065–1070 (2005).
  • Reid MC, Van Ness PH, Hawkins KA, Towle V, Concato J, Guo Z. Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care. J. Geriatr. Psychiatry Neurol.19(2), 98–105 (2006).
  • Yoshitake T, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study. Neurology45(6), 1161–1168 (1995).
  • Dufouil C, Tzourio C, Brayne C, Berr C, Amouyel P, Alperovitch A. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology11(3), 280–284 (2000).
  • Leibovici D, Ritchie K, Ledesert B, Touchon J. The effects of wine and tobacco consumption on cognitive performance in the elderly: a longitudinal study of relative risk. Int. J. Epidemiol.28(1), 77–81 (1999).
  • Stampfer MJ, Kang JH, Chen J, Cherry R, Grodstein F. Effects of moderate alcohol consumption on cognitive function in women. N. Engl. J. Med.352(3), 245–253 (2005).
  • Herbert LE, Taylor JO, Evans DA. Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. Am. J. Epidemiol.137(8), 881–891 (1993).
  • Broe GA, Creasey H, Jorm AF et al. Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust. N. Z. J. Public Health22(5), 621–623 (1998).
  • Cervilla JA, Prince M, Mann A. Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak Project. J. Neurol. Neurosurg. Psychiatry68(5), 622–626 (2000).
  • Galanis DJ, Joseph C, Masaki KH, Petrovitch H, Ross GW, White L. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia aging study. Am. J. Public Health90(8), 1254–1259 (2000).
  • Ngandu T, Helkala EL, Soininen H et al. Alcohol drinking and cognitive functions: findings from the Cardiovascular Risk Factors Aging and Dementia (CAIDE) Study. Dement. Geriatr. Cogn. Disord.23(3), 140–149 (2007).
  • Orgogozo JM, Dartigues JF, Lafont S et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol. (Paris)153(3), 185–192 (1997).
  • Lemeshow S, Letenneur L, Dartigues JF, Lafont S, Orgogozo JM, Commenges D. Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID Study. Am. J. Epidemiol.148(3), 298–306 (1998).
  • Ruitenberg A, van Swieten JC, Witteman JC et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet359(9303), 281–286 (2002).
  • Lindsay J, Laurin D, Verreault R et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol.156(5), 445–453 (2002).
  • Huang W, Qiu C, Winblad B, Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J. Clin. Epidemiol.55(10), 959–964 (2002).
  • Deng J, Zhou DH, Li J, Wang YJ, Gao C, Chen M. A 2-year follow-up study of alcohol consumption and risk of dementia. Clin. Neurol. Neurosurg.108(4), 378–383 (2006).
  • Kivipelto M, Helkala EL, Hänninen T et al. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal; population based study. BMJ322(7300), 1447–1451 (2001).
  • Fujishima M, Kiyohara Y. Incidence and risk factors of dementia in a defined elderly Japanese population the Hisayama study. Ann. NY Acad. Sci.977, 1–8 (2002).
  • Järvenpää T, Rinne JO, Koskenvuo M, Räihä I, Kaprio J. Binge drinking in midlife and dementia risk. Epidemiology16(6), 766–771 (2005).
  • Simons LA, Simons J, McCallum J, Friedlander Y. Lifestyle factors and risk of dementia: Dubbo study of the elderly. Med. J. Aust.184(2), 68–70 (2006).
  • Mehlig K, Skoog I, Guo X et al. Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg. Am. J. Epidemiol.167(6), 684–691 (2008).
  • Solfrizzi V, D’Introno A, Colacicco AM et al, Italian Longitudinal Study on Aging Working Group. Alcohol consumption; mild cognitive impairment; and progression to dementia. Neurology68(10), 1790–1789 (2007).
  • Anttila T, Helkala EL, Viitanen M et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ329(7465), 539 (2004).
  • Espeland MA, Gu L, Masaki KH et al. Association between reported alcohol intake and cognition: results from the Women’s Health Initiative Memory Study. Am. J. Epidemiol.161(3), 228–238 (2005).
  • Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing37(5), 505–512 (2008).
  • Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am. J. Geriatr. Psychiatry17(7), 542–555 (2009).
  • Mukamal KJ, Longstreth WT Jr, Mittleman MA, Crum RM, Siscovick DS. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study. Stroke32(9), 1939–1946 (2001).
  • Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog. Neurobiol.56(4), 385–431 (1998).
  • National Institute on Alcohol Abuse and Alcoholism. Alcohol Alert No. 46: Are Women More Vulnerable to Alcohol’s Effects? National Institutes of Health, MD, USA (1999).
  • Stancampiano R, Carta M, Cocco S, Curreli R, Rossetti ZL, Fadda F. Biphasic effects of ethanol on acetylcholine release in the rat prefrontal cortex. Brain Res.997(1), 128–132 (2004).
  • Naimi TS, Brown DW, Brewer RD et al. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking US adults. Am. J. Prev. Med.28(4), 369–373 (2005).
  • Palomaki H, Kaste M. Regular light-to-moderate intake of alcohol and the risk of ischemic stroke: is there a beneficial effect? Stroke24(12), 1828–1832 (1993).
  • den Heijer T, Vermeer SE, van Dijk EJ et al. Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia. Am. J. Clin. Nutr.80(4), 992–997 (2004).
  • Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT Jr, Mittleman MA, Siscovick DS. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA289(11), 1405–1413 (2003).
  • Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J. Nutr.128(6), 1003–1007 (1998).
  • Waterhouse AL. Wine phenolics. Ann. NY Acad. Sci.957(5), 21–36 (2002).
  • Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues J-F. Intake of flavonoids and risk of dementia. Eur. J. Epidemiol.16(4), 357–363 (2000).
  • Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s diseases. Free Radic. Biol. Med.32(12), 1264–1275 (2002).
  • Ding Q, Dimayuga E, Keller JN. Oxidative damage, protein synthesis, and protein degradation in Alzheimer’s disease. Curr. Alzheimer Res.4(1), 73–79 (2007).
  • Heinonen IM, Lehtonen PJ, Hopia AI. Antioxidant activity of berry and fruit wines and liquors. J. Agric. Food Chem.46(1), 25–31 (1998).
  • Albani D, Polito L, Forloni G. Sirtuins as novel targets for Alzheimer’s disease and other neurodegenerative disorders: experimental and genetic evidence. J. Alzheimers Dis.19(1), 11–26 (2010).
  • Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res.49(5), 472–481 (2005).
  • Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos.32(12), 1377–1382 (2004).
  • Brust JC. A 74-year-old man with memory loss and neuropathy who enjoys alcoholic beverages. JAMA299(9), 1046–1054 (2008).
  • Panza F, Capurso C, Solfrizzi V. Alcohol use, thiamine deficiency, and cognitive impairment. JAMA299(24), 2853–2854 (2008).
  • Hendrie HC, Osuntokun BO, Hall KS et al. Prevalence of Alzheimer’s disease and dementia in two communities: Nigerian–Africans and African–Americans. Am. J. Psychiatry152(10), 1485–1492 (1995).
  • White L, Petrovitch H, Ross GW et al. Prevalence of dementia in older Japanese–American men in Hawaii. JAMA276(12), 955–960 (1996).
  • Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch. Neurol.59(8), 1256–1263 (2002).
  • Steffen LM, Jacobs DR Jr, Stevens J, Shahar E, Carithers T, Folsom AR. Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr.78(3), 383–390 (2003).
  • Mizrahi A, Knekt P, Montonen J, Laaksonen MA, Heliövaara M, Järvinen R. Plant foods and the risk of cerebrovascular diseases: a potential protection of fruit consumption. Br. J. Nutr.102(7), 1075–1083 (2009).
  • La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am. J. Clin. Nutr.65(1), 20–29 (1997).
  • Salerno-Kennedy R, Cashman KD. Relationship between dementia and nutrition-related factors and disorders: an overview. Int. J. Vit. Nutr. Res.75(2), 83–95 (2005).
  • Ancelin ML, Christen Y, Ritchie K. Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dem. Geriatr. Cogn. Disord.24(1), 1–19 (2007).
  • Grodstein F, Chen J, Willet WC. High-dose antioxidant supplements and cognitive function in community-dweling elderly women. Am. J. Clin. Nutr.77(4), 3223–3229 (2003).
  • Engelhart MJ, Geerlinks MI, Ruitenberg A et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA287(24), 3223–3229 (2002).
  • Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer´s transgenic mouse. J. Neurosci.21(21), 8370–8377 (2001).
  • Conte V, Uryu K, Fujimoto S et al. Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury. J. Neurochem.90(3), 758–764 (2004).
  • Huang HY, Caballero B, Chang S et al. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann. Intern. Med.145(5), 372–385 (2006).
  • Sano M, Ernesto C, Thomas RG et al. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer´s disease. N. Engl. J. Med.336(17), 1216–1222 (1997).
  • Le Bars PL, Velasco VM, Fergunson JM, Dessain EC, Keiser M, Hoerr R. Influence of the severity of cognitive impairment on the effect of Gingko biloba extract Egb 761 in Alzheimer´s disease. Neuropsychobiology45(1), 19–26 (2002).
  • Petersen RC, Thomas RG, Grundman M et al. Vitamin E and donepezil for the treatment of mild cognitive impairment Alzheimer’s Disease Cooperative Study Group. N. Engl. J. Med.352(23), 2379–2388 (2005).
  • Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J. Alzheimer Dis.15(3), 473–493 (2008).
  • Lee L, Kang SA, Lee HO et al. Relationships between dietary intake and cognitive function level in Korean elderly people. Public Health115(2), 133–128 (2001).
  • Kang JH, Ascherio A, Grodstein F. Fruit and vegetable consumption and cognitive decline in aging women. Ann. Neurol.57(5), 713–720 (2005).
  • Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology67(8), 1370–1376 (2006).
  • Hughes TF, Andel R, Small BJ et al. Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins. Am. J. Geriatr. Psychiatry18(5), 413–420 (2010).
  • Mecocci P, Mariani E, Polidori MC, Hensley K, Butterfield DA. Antioxidant agents in Alzheimer’s disease. Centr. Nerv. Syst. Ag. Med. Chem.8, 48–63 (2008).
  • Polidori MC, Praticó D, Mangialasche F et al. High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J. Alzheimer Dis.17(4), 921–927 (2009).
  • Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol.3(6), 343–353 (2004).
  • Van Dyk K, Sano M. The impact of nutrition on cognition in the elderly. Neurochem. Res.32(4–5), 893–904 (2007).
  • Letenneur L, Proust-Lima C, Le Gouge A, Dartigues J, Barberger-Gateau P. Flavonoid intake and cognitive decline over a 10-year period. Am. J. Epidemiol.165(12), 1364–1371 (2007).
  • Gray SL, Anderson ML, Crane PK et al. Antioxidant vitamin supplement use and risk of dementia or Alzheimer’s disease in older adults. J. Am. Geriatr. Soc.56(2), 291–295 (2008).
  • Sonnen JA, Larson EB, Gray SL et al. Free radical damage to cerebral cortex in Alzheimer’s disease, microvascular brain injury, and smoking. Ann. Neurol.65(2), 226–229 (2009).
  • Morris MC, Evans DA, Tangney CC et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am. J. Clin. Nutr.81(2), 508–514 (2005).
  • Morris MC, Evans DA, Bienias JL et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA287(24), 3230–3237 (2002).
  • Smith MA, Hirai K, Hsiao K et al. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem.70(5), 2212–2215 (1998).
  • Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic. Biol. Med.36(5), 592–604 (2004).
  • Ortiz D, Shea TB. Apple juice prevents oxidative stress induced by amyloid-β in culture. J. Alzheimer Dis.6(1), 27–30 (2004).
  • Heo HJ, Lee CY. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J. Agric. Food Chem.52(6), 7514–7517 (2004).
  • Nakayama T. Suppression of hydroperoxide-induced cytotoxicity by polyphenols. Cancer Res.54(7 Suppl.), S1991–S1993 (1994).
  • Patil CS, Singh VP, Satyanarayan PS, Jain NK, Singh A, Kulkarni SK. Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology69(2), 59–67 (2003).
  • Rogers EJ, Milhalik S, Orthiz D, Shea TB. Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice. J. Nutr. Health Aging8(2), 92–97 (2004).
  • Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Vitamin E and cognitive decline in older persons. Arch. Neurol.59(7), 1125–1132 (2002).
  • Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology65(8), 1193–1197 (2005).
  • Imbimbo BP, Solfrizzi V, Panza F. Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment? Front. Aging Neurosci.2. Pii, 19 (2010).
  • Breitner JC, Haneuse SJ, Walker R et al. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology72(22), 1899–1905 (2009).
  • Sonnen JA, Larson EB, Walker RL et al. Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology75(13), 1203–1210 (2010).
  • Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH. Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am. J. Clin. Nutr.83(3), 567–574 (2006).
  • Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr.79(5), 727–747 (2004).
  • Sanchez-Moreno C, Cano MP et al. High-pressurized orange juice consumption affects plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. J. Nutr.133(7), 2204–2209 (2003).
  • Kiefer I, Prock P, Lawrence C et al. Supplementation with mixed fruit and vegetable juice concentrates increased serum antioxidants and folate in healthy adults. J. Am. Coll. Nutr.23(3), 205–211 (2004).
  • Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer’s disease. Neurology56(9), 1188–1194 (2001).
  • Féart C, Samieri C, Barberger-Gateau P. Mediterranean diet and cognitive function in older adults. Curr. Opin. Clin. Nutr. Metab. Care13(1), 14–18 (2010).
  • Kant AK. Dietary patterns and health outcomes. J. Am. Diet. Assoc.104(4), 615–635 (2004).
  • Kourlaba G, Panagiotakos DB. Dietary quality indices and human health: a review. Maturitas62(1), 1–8 (2009).
  • Rumawas ME, Dwyer JT, McKeown NM, Meigs JB, Rogers G, Jacques PF. The development of the Mediterranean-style dietary pattern score and its application to the American diet in the Framingham Offspring Cohort. J. Nutr.139(6), 1150–1156 (2009).
  • Trichopoulou A, Kouris-Blazos A, Wahlqvist ML et al. Diet and overall survival in elderly people. BMJ311(7018), 1457–1460 (1995).
  • Hu FB, Bronner L, Willett WC et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA287(14), 1815–1821 (2002).
  • Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer’s disease. Ann. Neurol.59(6), 912–921 (2006).
  • Scarmeas N, Stern Y, Mayeux R, Luchsinger JA. Mediterranean diet, Alzheimer disease, and vascular mediation. Arch. Neurol.63(12), 1709–1717 (2006).
  • Scarmeas N, Luchsinger JA, Mayeux R, Stern Y. Mediterranean diet, and Alzheimer disease mortality. Neurology69(11), 1084–1093 (2007).
  • Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch. Neurol.66(2), 216–225 (2009).
  • Féart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA302(6), 638–648 (2009).
  • Scarmeas N, Luchsinger JA, Schupf N et al. Physical activity, diet, and risk of Alzheimer disease. JAMA302(6), 627–637 (2009).
  • Gu Y, Luchsinger JA, Stern Y, Scarmeas N. Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer’s disease. J. Alzheimers Dis.22(2), 483–492 (2010).
  • Solfrizzi V, Capurso C, D’Introno A, Colacicco AM, Capurso A, Panza F. Whole-diet approach and risk of chronic disease: limits and advantages. J. Am. Geriatr. Soc.54(11), 1800–1802 (2006).
  • Trichopoulou A, Bamia C, Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ338, b2337 (2009).
  • Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev. Med.44(4), 335–340 (2007).
  • Guenther PM, Reedy J, Krebs-Smith SM. Development of the Healthy Eating Index-2005. J. Am. Diet. Assoc.108(11), 1896–1901 (2008).
  • Tangney CC, Kwasny MJ, Li H, Wilson RS, Evans DA, Morris MC. Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am. J. Clin. Nutr.93(3), 601–607 (2011).
  • Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. Food combination and Alzheimer disease risk: a protective diet. Arch. Neurol.67(6), 699–706 (2010).
  • Renaud S, de Lorgeril M, Delaye J et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am. J. Clin. Nutr.61(6 Suppl.), S1360–S1367 (1995).
  • Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA Study. J. Am. Coll. Cardiol.44(1), 152–158 (2004) .
  • Singh RB, Dubnov G, Niaz MA et al. Effect of an Indo–Mediterranean diet on progression of coronary artery disease in high risk patients (Indo–Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet360(9344), 1455–1461 (2002).
  • Psaltopoulou T, Naska A, Orfanos P, Trichopoulos D, Mountokalakis T, Trichopoulou A. Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am. J. Clin. Nutr.80(4), 1012–1018 (2004).
  • de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation99(6), 779–785 (1999).
  • Gauthier S, Reisberg B, Zaudig M et al. Mild cognitive impairment. Lancet367(9518), 1262–1270 (2006).
  • Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology63(7), 1187–1192 (2004).
  • Watson GS, Craft S. The role of insulin resistance in the pathogenesis of Alzheimer’s disease: implications for treatment. CNS Drugs17(1), 27–45 (2003).
  • Reger MA, Watson GS, Green PS et al. Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology70(6), 440–448 (2008).
  • Zhao Z, Xiang Z, Haroutunian V, Buxbaum JD, Stetka B, Pasinetti GM. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer’s disease. Neurobiol. Aging28(6), 824–830 (2007).
  • Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology63(4), 658–663 (2004).
  • Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch. Neurol.64(4), 570–575 (2007).
  • Esposito K, Marfella R, Ciotola M et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA292(12), 1440–1446 (2004).
  • Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Rönnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA287(5), 598–605 (2002).
  • Dai J, Jones DP, Goldberg J et al. Association between adherence to the Mediterranean diet and oxidative stress. Am. J. Clin. Nutr.88(5), 1364–1370 (2008).
  • Harris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care21(4), 518–524 (1998).
  • Keller JN, Schmitt FA, Scheff SW et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology64(7), 1152–1156 (2005).
  • Mecocci P. Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. J. Alzheimers Dis.6(2), 159–163 (2004).
  • Fito M, Cladellas M, de la Torre R et al. Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis181(1), 149–158 (2005).
  • Szeto YT, Tomlinson B, Benzie IF. Total antioxidant and ascorbic acid content of fresh fruits and vegetables: implications for dietary planning and food preservation. Br. J. Nutr.87(1), 55–59 (2002).
  • Byers T, Perry G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu. Rev. Nutr.12, 139–159 (1992).
  • Stupans I, Kirlich A, Tuck KL, Hayball PJ. Comparison of radical scavenging effect, inhibition of microsomal oxygen free radical generation, and serum lipoprotein oxidation of several natural antioxidants. J. Agric. Food Chem.50(8), 2464–2469 (2002).
  • Mancini M, Parfitt VJ, Rubba P. Antioxidants in the Mediterranean diet. Can. J. Cardiol.11(Suppl. G), G105–G109 (1995).
  • Blum S, Aviram M, Ben-Amotz A, Levy Y. Effect of a Mediterranean meal on postprandial carotenoids, paraoxonase activity and C-reactive protein levels. Ann. Nutr. Metab.50(1), 20–24 (2006).
  • Wallace AJ, Sutherland WH, Mann JI, Williams SM. The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes. Eur. J. Clin. Nutr.55(11), 951–958 (2001).
  • Aviram M, Dornfeld L, Rosenblat M et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr.71(5), 1062–1076 (2000).
  • Sanchez-Moreno C, Cano MP, de Ancos B et al. Mediterranean vegetable soup consumption increases plasma vitamin C and decreases F2-isoprostanes, prostaglandin E2 and monocyte chemotactic protein-1 in healthy humans. J. Nutr. Biochem.17(3), 183–189 (2006).
  • Giugliano D, Esposito K. Mediterranean diet and metabolic diseases. Curr. Opin. Lipidol.19(1), 63–68 (2008).
  • Panagiotakos DB, Dimakopoulou K, Katsouyanni K et al. Mediterranean diet and inflammatory response in myocardial infarction survivors. Int. J. Epidemiol.38(3), 856–866 (2009).
  • Weninger SC, Yankner BA. Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat. Med.7(5), 527–528 (2001).
  • Walsh S, Aisen PS. Inflammatory processes and Alzheimer’s disease. Expert Rev. Neurother.4(5), 793–798 (2004).
  • Galimberti D, Schoonenboom N, Scheltens P et al. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch. Neurol.63(4), 538–543 (2006).
  • Guerreiro RJ, Santana I, Bras JM, Santiago B, Paiva A, Oliveira C. Peripheral inflammatory cytokines as biomarkers in Alzheimer’s disease and mild cognitive impairment. Neurodegener. Dis.4(6), 406–412 (2007).
  • Magaki S, Mueller C, Dickson C, Kirsch W. Increased production of inflammatory cytokines in mild cognitive impairment. Exp. Gerontol.42(3), 233–240 (2007).
  • Iwamoto N, Nishiyama E, Ohwada J, Arai H. Demonstration of CRP immunoreactivity in brains of Alzheimer’s disease: immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci. Lett.177(1–2), 23–26 (1994).
  • Duong T, Nikolaeva M, Acton PJ. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer’s disease. Brain Res.749(1), 152–156 (1997).
  • McGeer EG, Yasojima K, Schwab C, McGeer PL. The pentraxins: possible role in Alzheimer’s disease and other innate inflammatory diseases. Neurobiol. Aging22(6), 843–848 (2001).
  • Wood JA, Wood PL, Ryan R et al. Cytokine indices in Alzheimer’s temporal cortex: no changes in mature IL-1 β or IL-1RA but increases in the associated acute phase proteins IL-6, α 2-macroglobulin and C-reactive protein. Brain Res.629(2), 245–252 (1993).
  • Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann. Neurol.52(2), 168–174 (2002).
  • Frank RA, Galasko D, Hampel H et al. Biological markers for therapeutic trials in Alzheimer’s disease: proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer’s disease. Neurobiol. Aging24(4), 521–536 (2003).
  • Roberts RO, Geda YE, Knopman DS et al. Association of C-reactive protein with mild cognitive impairment. Alzheimers Dement.5(5), 398–405 (2009).
  • Paschos GK, Rallidis LS, Liakos GK et al. Background diet influences the anti-inflammatory effect of α-linolenic acid in dyslipidaemic subjects. Br. J. Nutr.92(4), 649–655 (2004).
  • Fung TT, McCullough ML, Newby P et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am. J. Clin. Nutr.82(1), 163–173 (2005).
  • Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology59(3), 371–378 (2002).
  • Engelhart MJ, Geerlings MI, Meijer J et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch. Neurol.61(5), 668–672 (2004).
  • Bertelli AA, Migliori M, Panichi V et al. Oxidative stress and inflammatory reaction modulation by white wine. Ann. NY Acad. Sci.957, 295–301 (2002).
  • Solfrizzi V, Frisardi V, Capurso C et al. Whole-diet approach: working on a criterion validity for age-related cognitive decline and mild cognitive impairment. J. Am. Geriatr. Soc.57(10), 1944–1946 (2009).
  • Jacques PF, Tucker KL. Are dietary patterns useful for understanding the role of diet in chronic disease? Am. J. Clin. Nutr.73(1), 1–2 (2001).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.